BioCentury
ARTICLE | Financial News

Isis plans $175M note deal

August 7, 2012 1:10 AM UTC

Isis Pharmaceuticals Inc. (NASDAQ:ISIS) said late Monday it plans to sell $175 million in senior unsecured convertible notes due 2019 to institutional investors. Earlier in the day, Isis announced dur...